PYMNTS.com October 22, 2024

Hospitals are adopting AI assistants for patient care and Microsoft is rolling out medical imaging models, while the U.S. Food and Drug Administration (FDA) calls for vigilant monitoring of these rapidly evolving tools. The push toward AI integration promises to ease healthcare worker burnout and improve diagnostics, but regulators warn that these powerful new systems require continuous oversight to ensure patient safety.

FDA Calls for Monitoring of AI Medical Tools

According to a new FDA perspective published in JAMA, the Food and Drug Administration is pushing for continuous monitoring of artificial intelligence tools used in healthcare. The agency warns that unmonitored AI systems could pose risks to patient safety.

The agency, which has authorized nearly 1,000 AI-enabled medical devices to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Health System / Hospital, Provider, Technology
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article